This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qilu Puget Sound Biotherapeutics Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jamil Haque: Innovator in Biotherapeutics
Introduction
Jamil Haque is a prominent inventor based in Bothell, WA (US). He has made significant contributions to the field of biotherapeutics, particularly through his innovative work on antibodies.
Latest Patents
Jamil Haque holds a patent for "ANTI-CCR8 ANTIBODIES." This patent represents a crucial advancement in therapeutic options for various diseases, showcasing his expertise and dedication to improving healthcare.
Career Highlights
Haque is currently employed at Qilu Puget Sound Biotherapeutics Corporation, where he continues to push the boundaries of biotherapeutic research. His work has garnered attention for its potential impact on treatment methodologies.
Collaborations
Throughout his career, Jamil has collaborated with notable colleagues, including Wei Yan and Zhi Liu. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jamil Haque's contributions to the field of biotherapeutics, particularly through his patent on anti-CCR8 antibodies, highlight his role as a key innovator in the industry. His ongoing work at Qilu Puget Sound Biotherapeutics Corporation promises to lead to further advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile